Newsroom

ANNAPOLIS, Md. & MALVERN, Pa.--(BUSINESS WIRE)--Care for HER provides Black breast cancer patients free integrative therapies and 24/7 nurse navigation. TOUCH BBCA and Unite for HER expand access....

MIAMI--(BUSINESS WIRE)--Treasure AI, the Agentic Experience Platform, wrapped Agentic World 2026 last week at the JW Marriott Miami Turnberry Resort & Spa. Across three days (Oct. 5–7), more than 500 enterprise marketing, data and technology leaders saw agentic AI move from slideware to live execution, including a keynote where Treasure AI took a clothing brand from idea to ready-to-send customer journey in real time. Treasure AI CEO and Co-founder Kaz Ohta announced Digital Worker, a gover...

TAIPEI, Taiwan--(BUSINESS WIRE)--beflo Tenon wins a 2026 Forbes Vetted Smart Home Award, recognizing its innovative integration of smart technology and workspace design....

NEW YORK--(BUSINESS WIRE)--MidOcean Partners (“MidOcean”), a premier alternative asset manager specializing in middle-market private equity, alternative credit, and structured equity, announced today that it has formed a joint venture with Idea Financial (“Idea” or the “Company”), a Miami-based, technology-enabled small business lender. The joint venture will provide up to $225 million of capital to fund loans of up to $1 million to established small businesses, expanding Idea Financial’s offer...

WALTHAM, Mass.--(BUSINESS WIRE)--Palleon Pharmaceuticals, a clinical-stage biotechnology company developing novel therapeutics for autoimmunity and cancer, will deliver an oral presentation at the 2026 American College of Rheumatology (ACR) Convergence, taking place November 6-11 in Orlando, Florida. Palleon's presentation will take place on Wednesday, November 11. Details of Palleon's Presentation: American College of Rheumatology (ACR) Convergence Title: Rapid and deep clinical responses to H...

ATLANTA--(BUSINESS WIRE)--Atlanta Braves Holdings, Inc. (NASDAQ: BATRA, BATRK) announced that it will host a conference call to discuss results for the third quarter of 2026 on November 4, 2026 at 10:00 a.m. ET. Before the open of market trading that day, Atlanta Braves Holdings will issue a press release reporting such results, which can be found at https://www.bravesholdings.com/news/press-releases. The press release and conference call may include a discussion of the company’s financial perfo...

ORLANDO, Fla.--(BUSINESS WIRE)--ModMed®, a leading provider of software and services to specialty medical practices, today announced ModMed AI Analytics, a new analytics platform that embeds AI across the company's reporting toolset and will replace its existing analytics solution. ModMed introduced the new toolset at its MOMENTUM user conference 2026 in Orlando. "Specialty practices are sitting on more data than ever, and far too little of it reaches the people who need it in time to act," sai...

NEW YORK--(BUSINESS WIRE)--Fantasy, the independent product design and build firm founded in 1999, today announced that it has been recognized in the Gartner® report Cutting-Edge Providers to Watch in Intelligent Products and Services Innovation Services, published September 16, 2026. This is Fantasy’s first inclusion in Gartner research. Fantasy’s intelligent systems work replaces one-size-fits-all digital products with experiences that adapt to each person and keep improving after launch. At...

OAKLAND, Calif.--(BUSINESS WIRE)--Marqeta, Inc. (NASDAQ: MQ), the modern card issuing platform, today announced a collaboration with Coinbase, the leading regulated cryptocurrency exchange, to bring stablecoin-backed cards to both crypto-native and non-crypto firms. Leveraging Coinbase's crypto infrastructure, Marqeta will enable businesses to offer a payment card solution that allows users to tap into the benefits of stablecoins by turning their stablecoin balances into everyday card spend. Th...

PHILADELPHIA--(BUSINESS WIRE)--Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing T cell-based immunotherapies that contain checkpoint modifiers, today announced that an abstract reporting long-term follow-up data of VRON-0200, its novel, first-in-class, immunotherapy for HBV Functional Cure, has been selected for a late-breaking oral presentation at The Liver Meeting® 2026, the annual meeting of the American Association for the Study of Liver Diseases (AASLD), to be h...